NCT01967732View on ClinicalTrials.gov

Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 (THS 2.2)

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

July 31, 2014

Conditions
Smoking
Interventions
OTHER

THS 2.2

Single use of the Tobacco Heating System 2.2 (THS 2.2)

OTHER

CC

Single use of subject's own conventional cigarette (CC)

OTHER

NNS

Single administration of 1 mg of nicotine

Trial Locations (1)

BT9 6AD

Celerion GB Ltd, 22-24 Lisburn Road, Belfast

All Listed Sponsors
lead

Philip Morris Products S.A.

INDUSTRY

NCT01967732 - Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 (THS 2.2) | Biotech Hunter | Biotech Hunter